CAM
EPZM

ClariVest Asset Management’s Epizyme, Inc EPZM Stock Holding History

ClariVest Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-57,370
Closed -$922K – 876
2020
Q2 		$922K Sell
57,370
-1,340
-2% -$23.4K 0.03% 331
2020
Q1 		$911K Buy
58,710
+29
+0% +$623 0.03% 317
2019
Q4 		$1.44M Buy
+58,681
New +$871K 0.03% 295

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

ClariVest Asset Management's EPZM Position: Q3 2020 in Review

ClariVest Asset Management sold out of Epizyme, Inc (EPZM) in Q3 2020, closing a stake of 57,370 shares — an estimated $922K sold.

ClariVest Asset Management first reported a position in EPZM in Q4 2019 and held it in 3 quarters. The position peaked at $1.44M in Q4 2019. 151 funds tracked by Wall St. Rank hold EPZM as of Q3 2020.

  • ClariVest Asset Management reported no remaining Epizyme, Inc position as of Q3 2020 after selling out during the quarter.
  • ClariVest Asset Management sold 57,370 Epizyme, Inc shares in Q3 2020, an estimated $922K.
  • ClariVest Asset Management first reported a position in Epizyme, Inc in Q4 2019 and held it in 3 quarters.
  • ClariVest Asset Management's Epizyme, Inc position peaked at $1.44M in Q4 2019.
  • 151 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2020.

Based on ClariVest Asset Management's 13F filing for Q3 2020, filed 9 Nov 2020.